KITE PHARMA

Serial Number 86417608
606

Registration Progress

Application Filed
Oct 7, 2014
Under Examination
Jul 7, 2015
Approved for Publication
May 12, 2015
Published for Opposition
May 12, 2015
Registered

Trademark Image

KITE PHARMA

Basic Information

Serial Number
86417608
Filing Date
October 7, 2014
Published for Opposition
May 12, 2015
Abandonment Date
August 13, 2018
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 13, 2018
Classes
005

Rights Holder

Kite Pharma, Inc.

03
Address
2225 Colorado Ave.
Santa Monica, CA 90404

Ownership History

Kite Pharma, Inc.

Original Applicant
03
Santa Monica, CA

Kite Pharma, Inc.

Owner at Publication
03
Santa Monica, CA

Legal Representation

Attorney
Christina L. Martini

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

46 events
Date Code Type Description Documents
Oct 5, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 5, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 13, 2018 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 13, 2018 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Dec 22, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 21, 2017 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 20, 2017 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 19, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 19, 2017 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 13, 2017 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 13, 2017 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 21, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 19, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 19, 2017 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 19, 2017 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 5, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 3, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 3, 2017 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 3, 2017 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 5, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 4, 2016 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 3, 2016 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 6, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 6, 2016 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 7, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 5, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 5, 2016 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 5, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 7, 2015 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 12, 2015 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 12, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 22, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 3, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Apr 1, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 31, 2015 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 31, 2015 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 31, 2015 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 31, 2015 ALIE A ASSIGNED TO LIE Loading...
Mar 31, 2015 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 2, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 2, 2015 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 2, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 26, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 15, 2014 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 14, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 10, 2014 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for T Cell therapy; biological preparations for the treatment of cancer and tumors
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the wording "KITE PHARMA" and the design of a stylized triangular kite.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA"